Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has transformed weight management by reducing appetite through GLP-1 receptor activation in the brain. Real-world data reveals that average semaglutide weight loss ranges from 10% to 22% of starting body weight over 52 weeks, though individual outcomes depend on genetics, adherence, and metabolic factors. PlexusDx offers compounded semaglutide injections starting at $149/month, designed to fit diverse weight loss timelines and budgets.
Clinical Trial Weight Loss Data for Semaglutide
The landmark STEP trials, which studied once-weekly semaglutide injections in people with obesity, documented mean weight loss of 9.8 kg (21.5 lbs) at the 1.0 mg dose and 10.2 kg (22.5 lbs) at the 2.4 mg dose over one year. These results represent approximately 10-15% reduction from baseline body weight in participants who completed the full protocol. Notably, weight loss continued across all 68 weeks of treatment, with most rapid change occurring in the first 4-8 weeks as the body adapted to appetite suppression.
Secondary analyses revealed that approximately 35-45% of semaglutide users achieved ≥15% weight loss, while 10-20% achieved ≥20% weight loss. These outcomes surpassed earlier diabetes medications like liraglutide (typically 5-7% loss) and demonstrated semaglutide's distinct potency for metabolic change. Individual results varied significantly: some patients lost 5-10% while others exceeded 25%, highlighting the role of personal response patterns and genetic predisposition.
Factors That Influence Your Maximum Weight Loss Potential
Genetic variation in GLP-1 receptor sensitivity, FTO gene expression, and melanocortin pathway function directly shape how much weight loss each person can realistically expect. PlexusDx Precision Peptide Genetic Test maps 14 distinct metabolic pathways and screens key variants like GLP1R rs6923761 and FTO rs9939609 to reveal your peptide-pathway predispositions. Patients with favorable genetic profiles often experience earlier appetite suppression and steadier weight decline, while those with less responsive pathways may need higher doses or longer treatment duration to see comparable results.
Beyond genetics, consistent medication adherence, weekly injection timing, dietary quality, and physical activity level are powerful modifiers of weight loss outcomes. Patients who maintain regular meal structure, prioritize protein intake, and engage in 150+ minutes of weekly activity typically achieve 2-3 times greater weight loss than those relying solely on medication. Environmental factors like stress, sleep quality, and medication interactions also influence metabolic response and plateau timing.
Why Weight Loss Plateaus and How to Break Through
Most semaglutide users experience a plateau in weight loss between 12-24 weeks as the body adapts to the medication and metabolic rate decreases slightly. This is a normal physiological response, not a sign of treatment failure. Plateaus typically last 4-12 weeks before additional weight loss resumes, especially if lifestyle interventions are intensified or dose adjustments are made under clinical supervision.
Breaking through a plateau requires strategic changes: increasing exercise intensity, reducing caloric intake by 200-300 calories if safe and appropriate, optimizing sleep and stress management, or increasing medication dose if medically indicated. Some patients benefit from a medication adjustment after 8-12 weeks to higher strengths, which PlexusDx supports through tiered pricing that keeps your monthly cost flat—your dose may need to go up, but your price won't. Personalized genetic insights from the Precision Peptide test can guide whether your plateau stems from receptor sensitivity, appetite pathway activation, or lifestyle-driven causes.
Long-Term Weight Loss Maintenance and Dose Optimization
Clinical follow-up data spanning 2-3 years show that semaglutide users who maintain their dose and lifestyle changes preserve 80-90% of achieved weight loss long-term. Discontinuing treatment typically results in gradual weight regain over 6-12 months as appetite hormones normalize and metabolic adaptation reverses. This pattern underscores that semaglutide is a long-term metabolic management tool, similar to blood pressure or cholesterol medication, rather than a short-term diet.
PlexusDx compounded semaglutide injection starts at $149/month across all commitment tiers, with no flat per-compound pricing increases—ensuring affordability whether you maintain a 0.5 mg microdose or progress to 2.4 mg. The Precision Peptide Genetic Test ($99 add-on after first month) helps refine your expected weight loss timeline and dose responsiveness, reducing trial-and-error and optimizing your treatment plan from month one. HSA/FSA eligibility and availability across all 50 states make sustained, personalized semaglutide therapy accessible without insurance barriers.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I realistically lose in the first month on semaglutide?
Most patients lose 2-5 lbs in the first 4 weeks, primarily from appetite reduction and improved satiety rather than metabolic acceleration. Significant weight loss (8-12 lbs monthly) typically begins in weeks 3-8 once the body fully adapts to the medication. PlexusDx patients can track early response and adjust dosing strategy within their first month before deciding on long-term commitment.
Is 22% weight loss typical, or do most people lose less?
The 22% figure comes from high-responder patients in controlled trials. Real-world outcomes average 10-15% weight loss for most users, with 35-45% achieving ≥15% loss and only 10-20% reaching ≥20% loss. Your personal result depends on genetics, adherence, lifestyle, and how your body responds to GLP-1 receptor activation.
Can I keep my weight loss after stopping semaglutide?
Weight regain typically occurs over 6-12 months after discontinuation as appetite hormones rebound. However, behavioral changes (diet, exercise, sleep) developed during treatment often stick, mitigating some regain. Most experts recommend semaglutide as a long-term therapy rather than a short-term intervention.
Will my dose increase as I lose weight, and will that increase my monthly cost?
Your dose may increase during treatment for better results, but PlexusDx keeps your price flat—starting at $149/month for compounded semaglutide injection across all tiers. You'll never pay more simply because your dose went up, making long-term therapy predictable and affordable.
How does the Precision Peptide Genetic Test help predict my weight loss potential?
PlexusDx Precision Peptide Genetic Test screens 14 metabolic pathways and 49 peptides, including GLP1R, GIPR, FTO, and MC4R variants. These insights reveal your genetic predisposition for appetite control, fat metabolism, and GLP-1 responsiveness—helping predict your realistic weight loss timeline and optimal starting strategy for only $99 after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Split Doses of Mounjaro for Safe and Effective Weight Loss?
How Much Weight Can You Lose in Zepbound?